Authors: Hunger, RE Brand, CU Streit, M Eriksen, JA Gjertsen, MK Saeterdal, I Braathen, LR Gaudernack, G

Citation: Re. Hunger et al., Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant, EXP DERMATO, 10(3), 2001, pp. 161-167

Authors: Saeterdal, I Gjertsen, MK Straten, P Eriksen, JA Gaudernack, G

Citation: I. Saeterdal et al., A TGF beta RII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8(+) T cells, CANCER IMMU, 50(9), 2001, pp. 469-476

Authors: Saeterdal, I Bjorheim, J Lislerud, K Gjertsen, MK Bukholm, IK Olsen, OC Nesland, JM Eriksen, JA Moller, M Lindblom, A Gaudernack, G

Citation: I. Saeterdal et al., Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer, P NAS US, 98(23), 2001, pp. 13255-13260

Authors: Gjertsen, MK Buanes, T Rosseland, AR Bakka, A Gladhaug, I Soreide, O Eriksen, JA Moller, M Baksaas, I Lothe, RA Saeterdal, I Gaudernack, G

Citation: Mk. Gjertsen et al., Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma, INT J CANC, 92(3), 2001, pp. 441-450